Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

QGEN:US

25.1100 USD 0.0600 0.24%

As of 20:10:00 ET on 05/22/2015.

Snapshot for QIAGEN NV (QGEN)

Open: 24.9900 Day's Range: 24.8900 - 25.2000 Volume: 408,927
Previous Close: 25.0500 52wk Range: 20.7300 - 25.9100 1-Yr Rtn: +11.25%

Stock Chart for QGEN

No chart data available.
  • QGEN:US 25.1100
  • 1D
  • 1M
  • 1Y
25.0500
Interactive QGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QGEN

Current P/E Ratio (ttm) 37.8086
Estimated P/E(12/2015) 22.6625
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 0.6641
Est. EPS (USD) (12/2015) 1.1080
Est. PEG Ratio 2.4487
Market Cap (M USD) 5,826.10
Shares Outstanding (M) 232.02
30 Day Average Volume 798,875
Price/Book (mrq) 2.3649
Price/Sale (ttm) 4.5069
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QGEN

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Peer M SchatzCEO/Managing DirectorRoland SackersCFO/Managing Director
John GilardiVP:Corporate Communications
More Company Profile & Key Executives for QGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil